BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Month: September 2024

1 post
CEL-SCI Multikine Immunotherapy Boosts 5-Year Survival Rate in Head and Neck Cancer

Biotech NewsCEL-SCI’s Multikine Immunotherapy Boosts 5-Year Survival Rate in Head and Neck Cancer

  • BioTech Health X
  • September 16, 2024
CEL-SCI Corporation (NYSE American: CVM) has announced new breakthrough data from its Phase 3 trial of Multikine®, an…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Pasithea Therapeutics (KTTA) Just Raised $5 Million—Is This the Spark it Needed?
  • CNS Pharmaceuticals (CNSP) Might Be 2025’s Most Explosive Biotech Play
  • Nature’s Sunshine (NATR) is Crushing Expectations—Is a 2025 Rally Imminent?
  • The Honest Company (HNST) Could Be Wall Street’s Most Underrated Clean Brand Stock Right Now
  • Tivic Health (TIVC) Could Skyrocket in 2025
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • July 20, 2025
    Pasithea Therapeutics (KTTA) Just Raised $5 Million—Is This the Spark it Needed?
    • July 20, 2025
    CNS Pharmaceuticals (CNSP) Might Be 2025’s Most Explosive Biotech Play
    • July 20, 2025
    Nature’s Sunshine (NATR) is Crushing Expectations—Is a 2025 Rally Imminent?
    • July 20, 2025
    The Honest Company (HNST) Could Be Wall Street’s Most Underrated Clean Brand Stock Right Now
    • July 18, 2025
    Tivic Health (TIVC) Could Skyrocket in 2025
Recent Posts
  • Axogen (AXGN) is Reinventing Nerve Repair—And It Could Make Early Investors Rich
    • July 18, 2025
  • Pharvaris (PHVS): The $300M Biotech that Could Be the Next Big Thing in Pharma
    • July 18, 2025
  • Abeona Therapeutics (ABEO) s Set to Breakeven—And Analysts Say It’s Just the Beginning
    • July 18, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (251)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top